Fractional CTO in Raleigh: Getting Enterprise-Ready Before the First Deal
The Research Triangle produces a particular kind of founder. Technically deep, usually out of Duke, UNC or NC State, frequently with a PhD or a decade of industry research behind them. The region raised over two billion dollars across 290-plus deals in 2025, concentrated in life sciences, enterprise software, and increasingly AI and advanced manufacturing.
These founders are not short of technical ability. What catches them is something else, and it usually arrives attached to the first serious customer.
Section four of seven
A health system, a pharmaceutical company, a bank or a university sends across a vendor security review. Seven sections. Data residency. Access logging and retention periods. Encryption at rest and in transit. A complete subprocessor list. Incident response plan with defined notification timelines. Date of last penetration test. SOC 2 status.
The product works. The underlying science is sound. The pilot went well. And the company cannot answer section four.
What makes this expensive rather than merely irritating is that almost every one of those answers was fixed by architecture decisions made a year or more earlier, usually without anyone framing them as decisions at all.
The decisions that become someone else’s questionnaire
Whether the system records who accessed which record, and whether those logs are retained long enough to satisfy an auditor.
Whether customer data is isolated per tenant or shares a single database with a tenant identifier column.
Where credentials and keys live. A secrets manager is an answer. An environment file that was committed once and later removed is not.
Whether a staging environment exists that actually mirrors production.
Which third party services touch customer data, and whether anyone has kept a list.
Whether the system can delete a specific individual’s data on request without a manual database operation.
Every one of those is cheap to design in at the start and close to a rewrite to add afterwards. Per-tenant isolation decided on day one is a schema choice. Decided in year two it is a migration that touches every query in the system. None of them can be fixed in the six weeks between receiving the questionnaire and losing the deal to a competitor who could answer.
Why this is sharper in the Triangle than elsewhere
In most markets a startup’s first customers are other startups, which buy on product and worry about compliance later. Here the buyer pool looks different. Duke Health and UNC’s systems, IQVIA, Biogen, a life sciences cluster second only to Boston, plus the enterprise software base that grew up around Red Hat, SAS and IBM.
That means Triangle founders often meet a regulated enterprise buyer as their first real customer rather than their twentieth. The forgiving early market that startups in other cities use to figure things out largely does not exist here. Enterprise readiness stops being a later-stage concern and becomes a constraint on the architecture from the first sprint.
This is not a compliance project
Founders who hit this wall often respond by buying a compliance automation tool and starting a SOC 2 process. Both are reasonable and neither is the actual fix.
A compliance certificate attests that you follow the controls you claim to follow. It does not create the architecture those controls describe. If the system cannot tell you who accessed a record, no tool generates that capability. It just documents that you cannot.
The work is architectural and it has to happen in the codebase. That is a technical leadership job, and it is one of the clearest cases for having senior technical judgment involved long before the first enterprise conversation. The sequencing matters too. Starting an audit before the architecture supports the controls usually means paying for the process twice, once to discover the gaps and again once they are closed.
What a fractional CTO covers here
A fractional CTO is senior technical leadership applied to a defined set of decisions on an agreed schedule, without a full time salary or equity grant. For a Triangle company selling into regulated buyers, the work concentrates on a few specific things.
Designing the tenancy and data model so isolation is structural rather than enforced by application logic. Getting logging, access control and secrets management right early, when they cost very little. Keeping a subprocessor inventory from the first integration rather than reconstructing one under deadline. Sequencing the compliance path so it follows the architecture rather than trying to lead it. And sitting in the technical portion of customer and investor conversations, answering properly rather than promising to follow up.
The model is well established at this point. Industry data puts the US fractional workforce at roughly 150,000 people, with technology roles among the fastest growing categories inside it.
The other reason this matters here
Triangle deals take time. Local investors typically want to see an FDA pathway or signed enterprise contracts before a seed round, and rounds here often take 18 to 24 months to close. The upside is that a dollar of seed funding stretches considerably further than it would in Boston. The downside is that there are fewer chances to get it wrong.
A deal lost on a security questionnaire is not just that deal. In a market where a small number of institutional buyers talk to each other and to the same investors, it becomes part of how the company is described. Enterprise readiness is reputational here in a way it is not everywhere.
Where to start
Pull a standard vendor security questionnaire and try to fill it in honestly, today, before anyone asks you to. The rows you cannot answer are your technical roadmap, and finding them this way costs nothing compared to finding them inside a live deal.
Then decide who owns closing those gaps. If nobody on the team has taken a product through enterprise procurement before, that is the specific experience worth buying, and it is worth buying before the first review lands rather than during it.
Frequently Asked Questions
A questionnaire a prospective enterprise customer sends before purchasing, covering how a vendor handles data, access, encryption, third party services and security incidents. In regulated sectors it is a gate rather than a formality, and an incomplete response can end a deal regardless of how good the product is.
It depends on the buyer, but the more useful framing is that SOC 2 documents controls you already have. It does not create the underlying architecture. Companies that start the certification before the architecture supports it usually find the process stalls on technical gaps that take months to close.
A fractional CTO can make the architecture decisions that HIPAA compliance depends on, including access controls, audit logging, encryption, data isolation and subprocessor management, and can lead the technical side of a compliance programme. Certification itself involves auditors and legal counsel, so the work is complementary rather than a replacement.
Earlier in the Triangle than in most markets, because the first serious customer here is frequently a health system, a university or a large enterprise rather than another startup. The core decisions on logging, tenancy and access control belong in the first architecture conversation.
Technical depth in a research or engineering domain is not the same as experience taking a product through enterprise procurement and security review. Those are specific, learned skills. The gap is usually experience with the buying process, not engineering ability.
Availability and relevant experience matter more than location. What counts is whether they can be present for the decisions that matter, have taken a product through this kind of review before, and are reachable when a questionnaire lands with a two week deadline.
